HDAC3-YY1-RAB5A轴通过调节骨髓 stromal 细胞中的线粒体平衡来重塑AML支持的利基
Chao He1,2, Yue Xiong1,3, Yuqing Zeng1
1School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Shenzhen, China.
Cell death & disease
|July 7, 2025
概括
在骨髓 stromal 细胞 (BMSCs) 中准基因组脱乙酶3 (HDAC3) 减少白血病支持炎症,并增强急性髓性白血病 (AML) 治疗中的耐药性.
科学领域:
- 血液学 血液学 血液学
- 细胞生物学 细胞生物学
- 癌症生物学 癌症生物学
背景情况:
- 急性髓性白血病 (AML) 和骨髓 stromal 细胞 (BMSCs) 之间的相互作用对于白血病的进展和耐药性至关重要.
- 这种相互作用背后的机制及其在创造亲白血病利基中的作用尚未完全理解.
研究的目的:
- 阐明基因组脱乙酶3 (HDAC3) 在BMSCs中调节骨髓微环境并影响AML进展的作用.
- 调查针对BMSC中的HDAC3作为AML治疗策略的潜力.
主要方法:
- 针对炎症表型的AML患者衍生的BMSCs的表征.
- 通过RAB5A.A.对HDAC3在调节线粒体反应性氧物种 (ROS) 生产和线粒体衰变中的作用进行研究.
- 通过转录因子YY1.1.对HDAC3通过转录因子YY1.1.对RAB5A表达的调节进行分析.
- 评估HDAC3抑制对BMSC衰老,ROS产生,AML细胞存活率和耐药性的影响,包括与venetoclax的协同作用.
主要成果:
- 来自AML患者的BMSCs显示了一个超炎症的表型.
- 在BMSC中,HDAC3通过通过RAB5A抑制线粒体细胞的产生,从而促进线粒体ROS的产生,而RAB5A通过YY1.1进行调节.
- 过度的ROS加速了BMSC衰老,并促进了与衰老相关的分泌表型,创造了一个高炎症的利基,激活AML细胞中的NF-κB,增强生存和耐药性.
- 在BMSC中抑制HDAC3可降低ROS,延缓衰老,降低AML的扩散,并与venetoclax协同作用.
结论:
- 在BMSC中的HDAC3通过ROS生产和BMSC衰老驱动了一种亲白血病骨髓利基.
- 针对BMSC中的HDAC3提供了一种新的治疗方法,以重塑AML微环境并克服耐药性.
- 在BMSC中抑制HDAC3显示出对AML的组合治疗的潜力,提高了像venetoclax这样的药物的疗效.
更多相关视频
10:03Bioengineering of Humanized Bone Marrow Microenvironments in Mouse and Their Visualization by Live Imaging
Published on: August 1, 2017
11.8K
10:17Assessment of Cellular Bioenergetics in Mouse Hematopoietic Stem and Primitive Progenitor Cells using the Extracellular Flux Analyzer
Published on: September 24, 2021
2.8K
相关概念视频
Osteoclasts in Bone Remodeling
3.2K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.2K
Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Chromatin Modification in iPS Cells
1.9K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.9K
Multipotency of Hematopoietic Stem Cells
3.3K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.3K
Differentiation of Common Myeloid Progenitor Cells
3.3K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.3K
Stem Cell Niche
5.3K
The stem cell niche is the dynamic microenvironment where stem cells reside. Inside these niches, the cells may remain undifferentiated, undergo high self-renewal, or become lineage-specific progenitors. Stem cells coexist with other niche cells, such as stromal cells. They also interact closely with the ECM. Cell-cell and cell-matrix communication occur via adhesion molecules or soluble factors that signal the stem cells and determine their fate. Stromal cells also provide survival signals to...
5.3K
